Bonnie C. Carney , Monica L. Collins , Mary A. Oliver , John W. Keyloun , Lauren T. Moffatt , Jeffrey W. Shupp , Taryn E. Travis
{"title":"自体皮肤细胞悬浮液通过部分烧蚀激光辅助药物输送治疗低色素沉着疤痕不会导致短期重新色素沉着","authors":"Bonnie C. Carney , Monica L. Collins , Mary A. Oliver , John W. Keyloun , Lauren T. Moffatt , Jeffrey W. Shupp , Taryn E. Travis","doi":"10.1016/j.burns.2025.107603","DOIUrl":null,"url":null,"abstract":"<div><div>Post-burn hypertrophic scars often exhibit dyschromia, including hyper- and hypo-pigmentation. Inactivated melanocytes, typically residing in the epidermal basement membrane, pose a challenge for effective activation and repigmentation in scarred areas. This study explores an alternative approach: using laser-assisted drug delivery to transplant melanocyte-containing cell suspensions into hypopigmented scars. In a porcine model with induced scars, autologous skin cell suspensions (ASCS) were delivered via CO<sub>2</sub> fractional ablative laser-created channels. Longitudinal analysis using Image J revealed no increase in pigmented areas or discernible melanin levels by digital imaging or non-invasive probes at weeks 1 and 2. Histological examination further confirmed the absence of melanin in tissue biopsies, with a transient increase in epidermal thickness observed at Day 63. This approach did not achieve repigmentation of hypopigmented scars within the study's 2-week duration. Future investigations may refine this technique by modifying delivery protocols based on these findings.</div></div>","PeriodicalId":50717,"journal":{"name":"Burns","volume":"51 8","pages":"Article 107603"},"PeriodicalIF":2.9000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of hypopigmented scar with autologous skin cell suspension delivered through fractional ablative laser-assisted drug delivery does not lead to short-term re-pigmentation\",\"authors\":\"Bonnie C. Carney , Monica L. Collins , Mary A. Oliver , John W. Keyloun , Lauren T. Moffatt , Jeffrey W. Shupp , Taryn E. Travis\",\"doi\":\"10.1016/j.burns.2025.107603\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Post-burn hypertrophic scars often exhibit dyschromia, including hyper- and hypo-pigmentation. Inactivated melanocytes, typically residing in the epidermal basement membrane, pose a challenge for effective activation and repigmentation in scarred areas. This study explores an alternative approach: using laser-assisted drug delivery to transplant melanocyte-containing cell suspensions into hypopigmented scars. In a porcine model with induced scars, autologous skin cell suspensions (ASCS) were delivered via CO<sub>2</sub> fractional ablative laser-created channels. Longitudinal analysis using Image J revealed no increase in pigmented areas or discernible melanin levels by digital imaging or non-invasive probes at weeks 1 and 2. Histological examination further confirmed the absence of melanin in tissue biopsies, with a transient increase in epidermal thickness observed at Day 63. This approach did not achieve repigmentation of hypopigmented scars within the study's 2-week duration. Future investigations may refine this technique by modifying delivery protocols based on these findings.</div></div>\",\"PeriodicalId\":50717,\"journal\":{\"name\":\"Burns\",\"volume\":\"51 8\",\"pages\":\"Article 107603\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Burns\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0305417925002323\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Burns","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305417925002323","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
Treatment of hypopigmented scar with autologous skin cell suspension delivered through fractional ablative laser-assisted drug delivery does not lead to short-term re-pigmentation
Post-burn hypertrophic scars often exhibit dyschromia, including hyper- and hypo-pigmentation. Inactivated melanocytes, typically residing in the epidermal basement membrane, pose a challenge for effective activation and repigmentation in scarred areas. This study explores an alternative approach: using laser-assisted drug delivery to transplant melanocyte-containing cell suspensions into hypopigmented scars. In a porcine model with induced scars, autologous skin cell suspensions (ASCS) were delivered via CO2 fractional ablative laser-created channels. Longitudinal analysis using Image J revealed no increase in pigmented areas or discernible melanin levels by digital imaging or non-invasive probes at weeks 1 and 2. Histological examination further confirmed the absence of melanin in tissue biopsies, with a transient increase in epidermal thickness observed at Day 63. This approach did not achieve repigmentation of hypopigmented scars within the study's 2-week duration. Future investigations may refine this technique by modifying delivery protocols based on these findings.
期刊介绍:
Burns aims to foster the exchange of information among all engaged in preventing and treating the effects of burns. The journal focuses on clinical, scientific and social aspects of these injuries and covers the prevention of the injury, the epidemiology of such injuries and all aspects of treatment including development of new techniques and technologies and verification of existing ones. Regular features include clinical and scientific papers, state of the art reviews and descriptions of burn-care in practice.
Topics covered by Burns include: the effects of smoke on man and animals, their tissues and cells; the responses to and treatment of patients and animals with chemical injuries to the skin; the biological and clinical effects of cold injuries; surgical techniques which are, or may be relevant to the treatment of burned patients during the acute or reconstructive phase following injury; well controlled laboratory studies of the effectiveness of anti-microbial agents on infection and new materials on scarring and healing; inflammatory responses to injury, effectiveness of related agents and other compounds used to modify the physiological and cellular responses to the injury; experimental studies of burns and the outcome of burn wound healing; regenerative medicine concerning the skin.